A randomized placebo-controlled trial of infliximab therapy for active ulcerative colitis: Act I trial

被引：0
作者：
Rutgeerts, P
Feagan, BG
Olson, A
Johanns, J
Travers, S
Present, D
Sands, BE
Sandborn, W
Olson, A
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A35 / A36
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Cyrille, Marcoli
    Hansen, Mark Berner
    Feagan, Brian G.
    Loftus, Edward V., Jr.
    Rogler, Gerhard
    Vermeire, Severine
    Cruz, Martha L.
    Yang, Jun
    Boedigheimer, Michael J.
    Abuqayyas, Lubna
    Evangelista, Christine M.
    Sullivan, Barbara A.
    Reinisch, Walter
    GASTROENTEROLOGY, 2019, 156 (04) : 946 - +
  • [32] Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
    Reinshagen, Max
    Stallmach, Andreas
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (08): : 779 - 780
  • [33] RANDOMISED PLACEBO-CONTROLLED TRIAL OF RITUXIMAB (ANTI-CD20) IN ACTIVE ULCERATIVE COLITIS
    Leiper, K.
    Martin, K.
    Ellis, A.
    Subramanian, S.
    Watson, A.
    Christmas, S.
    Howarth, D.
    Campbell, F.
    Rhodes, J. M.
    GUT, 2010, 59 : A3 - A3
  • [34] Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
    Leiper, Keith
    Martin, Kate
    Ellis, Anthony
    Subramanian, Sreedhar
    Watson, Alastair J.
    Christmas, Steve E.
    Howarth, Deborah
    Campbell, Fiona
    Rhodes, Jonathan M.
    GUT, 2011, 60 (11) : 1520 - 1526
  • [35] Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial
    Nikkhah-Bodaghi, Mehrnaz
    Maleki, Iradj
    Agah, Shahram
    Hekmatdoost, Azita
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 43 : 1 - 6
  • [36] A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis
    Tilg, H
    Vogelsang, H
    Ludwiczek, O
    Lochs, H
    Kaser, A
    Colombel, JF
    Ulmer, H
    Rutgeerts, P
    Krüger, S
    Cortot, A
    D'Haens, G
    Harrer, M
    Gasche, C
    Wrba, F
    Kuhn, I
    Reinisch, W
    GUT, 2003, 52 (12) : 1728 - 1733
  • [37] Randomised Placebo-Controlled Trial of Rituximab (Anti-CD20) in Active Ulcerative Colitis
    Leiper, Keith
    Martin, Kate
    Ellis, Anthony
    Subramanian, Sreedhar
    Watson, Alastair J.
    Christmas, Stephen
    Howarth, Deborah
    Campbell, Fiona
    Rhodes, Jonathan M.
    GASTROENTEROLOGY, 2010, 138 (05) : S86 - S86
  • [38] Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
    Ben-Horin, Shomron
    GUT, 2012, 61 (02) : 327 - 327
  • [39] A double-blinded, randomized, placebo-controlled trial of infliximab in subects with active pulmonary sarcoidosis
    Rossman, Milton D.
    Newman, Lee S.
    Baughman, Robert P.
    Teirstein, Alvin
    Weinberger, Steven E.
    Miller, Wallace, Jr.
    Sands, Bruce E.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2006, 23 (03) : 201 - 208
  • [40] Vedolizumab Maintenance Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
    Feagan, Brian
    Rutgeerts, Paul
    Sands, Bruce
    Sandborn, William
    Colombel, Jean-Frederic
    Hanauer, Stephen
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S609 - S610
12345